Could less radiation be enough? new study tailors treatment for HPV+ throat cancer

NCT ID NCT03215719

Recruiting now Disease control Sponsor: NYU Langone Health Source: ClinicalTrials.gov ↗

First seen Jan 09, 2026 · Last updated Apr 30, 2026 · Updated 18 times

Summary

This study is for people with HPV-positive throat cancer. It tests whether doctors can safely lower the radiation dose during treatment if the tumor shrinks quickly and a blood test shows the cancer virus is clearing. The goal is to see if a lower dose still prevents the cancer from coming back for at least 2 years, while reducing side effects. About 120 participants will be enrolled.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

New York University School of Medicine
RECRUITING

New York, New York, 10016, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA OROPHARYNGEAL CARCINOMA